PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Optimal Duration of Antiplatelet Therapy Following Acute Coronary Syndrome.

Abstract This newsletter provides an overview of the available data pertaining to the optimal duration of dual antiplatelet therapy following an acute coronary syndrome, with a focus on individualized treatment plans to optimize patient outcomes.
PMID
Related Publications

Strategies to Optimize Dual Antiplatelet Therapy After Coronary Artery Stenting in Acute Coronary Syndrome.

State of the art: Oral antiplatelet therapy.

Duration of Dual Antiplatelet Therapy in the Post-Acute Coronary Syndrome Patient.

Systematic review of the clinical impact of dual antiplatelet therapy discontinuation after acute coronary syndromes.

The Benefits and Risks of Oral Antiplatelet Therapy in Patients with Acute Coronary Syndrome.

Authors

Mayor MeshTerms
Keywords
Journal Title the journal of family practice
Publication Year Start




PMID- 29261190
OWN - NLM
STAT- MEDLINE
DCOM- 20171227
LR  - 20171227
IS  - 1533-7294 (Electronic)
IS  - 0094-3509 (Linking)
VI  - 66
IP  - 12 Suppl
DP  - 2017 Dec
TI  - Optimal Duration of Antiplatelet Therapy Following Acute Coronary Syndrome.
LID - supp_az_1217 [pii]
AB  - This newsletter provides an overview of the available data pertaining to the
      optimal duration of dual antiplatelet therapy following an acute coronary
      syndrome, with a focus on individualized treatment plans to optimize patient
      outcomes.
FAU - Villanueva, Tomas
AU  - Villanueva T
AD  - Assistant Professor of Medicine, Nova Southeastern University, College of
      Osteopathic Medicine and Florida International University, College of Medicine,
      FL, USA.
LA  - eng
PT  - Journal Article
PT  - Review
PL  - United States
TA  - J Fam Pract
JT  - The Journal of family practice
JID - 7502590
RN  - 0 (Platelet Aggregation Inhibitors)
SB  - AIM
SB  - IM
MH  - Acute Coronary Syndrome/*drug therapy
MH  - Drug Synergism
MH  - Drug Therapy, Combination/*methods
MH  - Humans
MH  - Medication Therapy Management/standards
MH  - Patient Care Planning
MH  - Platelet Aggregation Inhibitors/*pharmacology
EDAT- 2017/12/21 06:00
MHDA- 2017/12/21 06:00
CRDT- 2017/12/21 06:00
PHST- 2017/12/21 06:00 [entrez]
PHST- 2017/12/21 06:00 [pubmed]
PHST- 2017/12/21 06:00 [medline]
AID - jfp_6612m [pii]
PST - ppublish
SO  - J Fam Pract. 2017 Dec;66(12 Suppl). pii: jfp_6612m.